Zimmer Biomet (NYSE:ZBH) Reaches New 12-Month Low – Here’s Why

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) shares reached a new 52-week low during mid-day trading on Monday . The stock traded as low as $79.60 and last traded at $79.1940, with a volume of 672006 shares traded. The stock had previously closed at $82.33.

Analysts Set New Price Targets

A number of research analysts recently commented on ZBH shares. Leerink Partners assumed coverage on Zimmer Biomet in a research note on Monday, April 13th. They issued a “hold” rating and a $101.00 price target for the company. Wall Street Zen raised shares of Zimmer Biomet from a “hold” rating to a “buy” rating in a report on Saturday. Needham & Company LLC restated a “hold” rating on shares of Zimmer Biomet in a research report on Tuesday, February 10th. William Blair started coverage on shares of Zimmer Biomet in a report on Friday, February 20th. They set a “market perform” rating for the company. Finally, Truist Financial reissued a “hold” rating and issued a $92.00 price objective (down from $98.00) on shares of Zimmer Biomet in a research note on Wednesday, April 29th. One equities research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, twelve have assigned a Hold rating and three have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $102.80.

Zimmer Biomet Stock Down 3.2%

The company has a quick ratio of 0.95, a current ratio of 1.73 and a debt-to-equity ratio of 0.50. The firm has a 50 day moving average of $91.56 and a two-hundred day moving average of $92.31. The firm has a market capitalization of $15.41 billion, a price-to-earnings ratio of 20.69, a price-to-earnings-growth ratio of 1.90 and a beta of 0.48.

Zimmer Biomet (NYSE:ZBH) last issued its earnings results on Tuesday, April 28th. The medical equipment provider reported $2.09 EPS for the quarter, topping the consensus estimate of $1.86 by $0.23. The firm had revenue of $2.09 billion during the quarter, compared to the consensus estimate of $2.07 billion. Zimmer Biomet had a return on equity of 13.24% and a net margin of 9.05%.The business’s quarterly revenue was up 9.3% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.81 earnings per share. Zimmer Biomet has set its FY 2026 guidance at 8.400-8.550 EPS. As a group, sell-side analysts anticipate that Zimmer Biomet Holdings, Inc. will post 8.47 EPS for the current fiscal year.

Zimmer Biomet Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Thursday, April 30th. Investors of record on Tuesday, March 31st were given a dividend of $0.24 per share. This represents a $0.96 dividend on an annualized basis and a yield of 1.2%. The ex-dividend date was Tuesday, March 31st. Zimmer Biomet’s dividend payout ratio is currently 24.94%.

Insider Buying and Selling

In related news, SVP Lori Winkler sold 2,650 shares of the stock in a transaction that occurred on Thursday, March 12th. The shares were sold at an average price of $94.66, for a total value of $250,849.00. Following the completion of the transaction, the senior vice president owned 10,224 shares of the company’s stock, valued at $967,803.84. This represents a 20.58% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 1.28% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of ZBH. M&T Bank Corp boosted its holdings in shares of Zimmer Biomet by 15,705.6% during the 4th quarter. M&T Bank Corp now owns 3,571,595 shares of the medical equipment provider’s stock valued at $321,158,000 after acquiring an additional 3,548,998 shares in the last quarter. Norges Bank bought a new stake in Zimmer Biomet during the 4th quarter worth $221,234,000. Franklin Resources Inc. increased its holdings in Zimmer Biomet by 43.2% in the 4th quarter. Franklin Resources Inc. now owns 6,685,987 shares of the medical equipment provider’s stock worth $601,204,000 after purchasing an additional 2,017,857 shares in the last quarter. Auto Owners Insurance Co increased its holdings in Zimmer Biomet by 8,892.0% in the 4th quarter. Auto Owners Insurance Co now owns 2,009,712 shares of the medical equipment provider’s stock worth $180,713,000 after purchasing an additional 1,987,362 shares in the last quarter. Finally, Dodge & Cox raised its position in Zimmer Biomet by 5.1% in the third quarter. Dodge & Cox now owns 23,216,173 shares of the medical equipment provider’s stock valued at $2,286,793,000 after purchasing an additional 1,118,710 shares during the last quarter. 88.89% of the stock is currently owned by institutional investors.

Zimmer Biomet Company Profile

Zimmer Biomet (NYSE: ZBH) is a global medical device company focused on musculoskeletal healthcare. Headquartered in Warsaw, Indiana, the company designs, manufactures and markets a broad portfolio of products used to treat joint disorders, bone disorders and related conditions. Its customer base includes orthopaedic and dental surgeons, hospitals, ambulatory surgery centers and other healthcare providers that rely on implants, instruments and related services for reconstructive and restorative procedures.

The company’s product offerings span joint replacement systems for hips, knees and shoulders; trauma and extremities implants; spine and thoracic solutions; dental and craniomaxillofacial implants and prosthetics; and sports medicine devices.